Van Hoang, Ph.D., has over 20 years of experience leading analytical organizations and developing medicines for patients globally. Her area of expertise is in bioprocess development of gene therapies, vaccines and therapeutic proteins. Van joined Spark Therapeutics in March 2020. She currently serves as Head of Analytical and Quality Control at Spark Therapeutics, where she leads an organization focused on analytical development, quality control testing and operations for assets spanning preclinical development through marketed products including asset lifecycle maintenance.
Before joining Spark Therapeutics in March 2020, Van was at Merck for 17 years. Van holds a Doctor of Philosophy degree in Pharmaceutical Chemistry from UCSF and a Bachelor of Science degree in Biochemistry from the UCLA graduating with Magna Cum Laude honors.